14 devices · GMDN 57685
This category includes immunoglobulins designed to bind to tyrosinase, an enzyme also known as DOPA oxidase, for use in laboratory testing. These antibodies are intended for the qualitative or quantitative detection of tyrosinase in clinical specimens, supporting diagnostic evaluation in pathology and research settings.
Devices in this category are in vitro diagnostic (IVD) reagents that rely on specific antigen-antibody interactions. They are regulated as IVDs and supplied for use in clinical laboratories, where they assist in identifying tyrosinase expression, particularly in melanocytic lesions, without implying any therapeutic function or standalone diagnostic approval.
This category summary is AI-generated from the GMDN nomenclature and has not been verified by a human reviewer.